Skip to content

Dolby Laboratories, Inc. DLB Share-Based Payment Award Options Outstanding - Number

Share-Based Payment Award Options Outstanding - Number at other companies

Piper Sandler logo
Piper SandlerPIPR
402.1K+201%
Balchem logo
BalchemBCPC
903K-9.2%
HQY
HealthEquityHQY
118K-64.9%
Perimeter Solutions logo
Perimeter SolutionsPRM
14.7M-17.4%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
10.6M-19.8%
Astera Labs, Inc. logo
Astera Labs, Inc.ALAB
2.6M-43.1%

Other financials

Income statement

See full
Revenue$395.6M+7.1%
Gross profit$350.9M+5.1%
Operating income$112.9M+4.8%
Net income$94.9M+3.4%
EPS (diluted)$0.99+5.3%

Balance sheet

See full
Cash & equivalents$673.8M-10.2%
Total debt$49.7M+22.9%
Total equity$2.6B+1.7%
Total assets$3.2B+0.6%

Cash flow

See full
Operating cash flow$92.5M-47.1%
CapEx$9.1M+31.4%
Free cash flow$83.4M-50.3%

Valuation

See full
Market cap$4.95B-25.9%

Profitability

See full
Gross margin87.4%-1.5pp
Operating margin18.5%-2.0pp
Net margin17.9%-1.6pp
FCF margin22.1%-7.5pp

Returns & leverage

See full
Return on equity9.4%-0.9pp
Debt / equity0.0×
Current ratio-0.1×

Where this comes from

Reported directly by Dolby Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.

The official record: Dolby Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dolby Laboratories, Inc.'s share-based payment award options outstanding - number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dolby Laboratories, Inc.'s share-based payment award options outstanding - number?
Dolby Laboratories, Inc. (DLB) reported share-based payment award options outstanding - number of 3.3M in Q3 2025.
How has Dolby Laboratories, Inc.'s share-based payment award options outstanding - number changed year-over-year?
Dolby Laboratories, Inc.'s share-based payment award options outstanding - number decreased by 6.1% year-over-year, from 3.5M to 3.3M.
What is the long-term trend for Dolby Laboratories, Inc.'s share-based payment award options outstanding - number?
Over 5 years (2020 to 2025), Dolby Laboratories, Inc.'s share-based payment award options outstanding - number has grown at a -13.2% compound annual growth rate (CAGR), from 6.6M to 3.3M.
What does share-based payment award options outstanding - number mean?
This is the total count of stock options granted to employees and directors that remain unexercised at the reporting date. It reflects the total volume of potential equity claims currently held by the workforce. This metric is a key component in calculating fully diluted share counts.